Neuroendocrine differentiation in castration-resistant prostate cancer: A case report

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1392-1394

Science Publishers

Access to resources Recommend Favorite

Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy

By Sternberg C. N.   Molina A.   North S.   Mainwaring P.   Fizazi K.   Hao Y.   Rothman M.   Gagnon D. D.   Kheoh T.   Haqq C. M.   Cleeland C.   de Bono J. S.   Scher H. I.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1017-1025

Oxford University Press

Access to resources Recommend Favorite

Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer

By Chi K.   Tolcher A.   Lee P.   Rosen P.   Kollmannsberger C.   Papadopoulos K.   Patnaik A.   Molina A.   Jiao J.   Pankras C.   Kaiser B.   Bernard A.   Tran N.   Acharya M.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 237-244

Springer Publishing Company

Access to resources Recommend Favorite

Durable complete remission with abiraterone in castration resistant metastatic prostate cancer

By Shah Binay Kumar   Shrestha Sunita  

Acta Oncologica, Vol. 52, Iss. 1, 2013-01 ,pp. : 174-174

Informa Healthcare

Access to resources Recommend Favorite

Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy: A case report

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 713-716

Spandidos Publications

Access to resources Recommend Favorite